nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—Canagliflozin—ALB—Crohn's disease	0.0212	1	CrCbGaD
Dapagliflozin—SLC5A4—digestive system—Crohn's disease	0.018	0.196	CbGeAlD
Dapagliflozin—SLC5A1—epithelium—Crohn's disease	0.0136	0.148	CbGeAlD
Dapagliflozin—SLC5A1—mammalian vulva—Crohn's disease	0.0118	0.128	CbGeAlD
Dapagliflozin—SLC5A1—digestive system—Crohn's disease	0.0103	0.112	CbGeAlD
Dapagliflozin—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.0102	0.0429	CcSEcCtD
Dapagliflozin—Vulvovaginal mycotic infection—Mesalazine—Crohn's disease	0.0098	0.0413	CcSEcCtD
Dapagliflozin—Neoplasm—Mercaptopurine—Crohn's disease	0.00892	0.0376	CcSEcCtD
Dapagliflozin—Lung disorder—Mesalazine—Crohn's disease	0.00757	0.0319	CcSEcCtD
Dapagliflozin—Neoplasm malignant—Azathioprine—Crohn's disease	0.00689	0.029	CcSEcCtD
Dapagliflozin—UGT1A9—digestive system—Crohn's disease	0.0065	0.0708	CbGeAlD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00633	0.00974	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00626	0.00963	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00626	0.00963	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.0056	0.00861	CbGpPWpGaD
Dapagliflozin—Neoplasm—Azathioprine—Crohn's disease	0.00532	0.0224	CcSEcCtD
Dapagliflozin—UGT2B4—Metapathway biotransformation—GPX4—Crohn's disease	0.00527	0.0081	CbGpPWpGaD
Dapagliflozin—UGT2B7—digestive system—Crohn's disease	0.00524	0.0571	CbGeAlD
Dapagliflozin—Vaginal infection—Mesalazine—Crohn's disease	0.00506	0.0213	CcSEcCtD
Dapagliflozin—Blood urea increased—Mesalazine—Crohn's disease	0.00506	0.0213	CcSEcCtD
Dapagliflozin—Multiple fractures—Prednisone—Crohn's disease	0.00488	0.0206	CcSEcCtD
Dapagliflozin—Fracture—Prednisone—Crohn's disease	0.00488	0.0206	CcSEcCtD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—GCKR—Crohn's disease	0.00481	0.00741	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—GCKR—Crohn's disease	0.00481	0.00741	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.0048	0.00739	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.0048	0.00739	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00457	0.00703	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00457	0.00703	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00441	0.00679	CbGpPWpGaD
Dapagliflozin—CYP1A1—mouth—Crohn's disease	0.0044	0.0479	CbGeAlD
Dapagliflozin—Malnutrition—Mercaptopurine—Crohn's disease	0.00432	0.0182	CcSEcCtD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00424	0.00653	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00424	0.00653	CbGpPWpGaD
Dapagliflozin—Thirst—Mesalazine—Crohn's disease	0.00409	0.0172	CcSEcCtD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.0039	0.006	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.0037	0.0057	CbGpPWpGaD
Dapagliflozin—Fungal infection—Prednisone—Crohn's disease	0.00367	0.0155	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00365	0.0154	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Mesalazine—Crohn's disease	0.00364	0.0154	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00355	0.015	CcSEcCtD
Dapagliflozin—Oedema—Mercaptopurine—Crohn's disease	0.00352	0.0148	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Mesalazine—Crohn's disease	0.00348	0.0147	CcSEcCtD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00346	0.00533	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00346	0.00533	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00346	0.00533	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00346	0.00533	CbGpPWpGaD
Dapagliflozin—Skin disorder—Mercaptopurine—Crohn's disease	0.00342	0.0144	CcSEcCtD
Dapagliflozin—Influenza—Mesalazine—Crohn's disease	0.00336	0.0142	CcSEcCtD
Dapagliflozin—Infestation NOS—Azathioprine—Crohn's disease	0.00329	0.0139	CcSEcCtD
Dapagliflozin—Infestation—Azathioprine—Crohn's disease	0.00329	0.0139	CcSEcCtD
Dapagliflozin—Angina pectoris—Mesalazine—Crohn's disease	0.00327	0.0138	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00322	0.00495	CbGpPWpGaD
Dapagliflozin—Dysuria—Mesalazine—Crohn's disease	0.00314	0.0132	CcSEcCtD
Dapagliflozin—Pollakiuria—Mesalazine—Crohn's disease	0.00311	0.0131	CcSEcCtD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00305	0.00469	CbGpPWpGaD
Dapagliflozin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00304	0.0128	CcSEcCtD
Dapagliflozin—UGT1A9—PPARA activates gene expression—FADS1—Crohn's disease	0.00302	0.00464	CbGpPWpGaD
Dapagliflozin—Infestation NOS—Mesalazine—Crohn's disease	0.003	0.0126	CcSEcCtD
Dapagliflozin—Infestation—Mesalazine—Crohn's disease	0.003	0.0126	CcSEcCtD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00295	0.00454	CbGpPWpGaD
Dapagliflozin—Renal failure—Mesalazine—Crohn's disease	0.00295	0.0124	CcSEcCtD
Dapagliflozin—Urinary tract infection—Mesalazine—Crohn's disease	0.00291	0.0123	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00284	0.00438	CbGpPWpGaD
Dapagliflozin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00278	0.0117	CcSEcCtD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00276	0.00425	CbGpPWpGaD
Dapagliflozin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Crohn's disease	0.00274	0.00421	CbGpPWpGaD
Dapagliflozin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00266	0.0112	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Mesalazine—Crohn's disease	0.00264	0.0111	CcSEcCtD
Dapagliflozin—Urethral disorder—Mesalazine—Crohn's disease	0.00264	0.0111	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—RSPO3—Crohn's disease	0.00263	0.00404	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00259	0.0109	CcSEcCtD
Dapagliflozin—CYP1A1—epithelium—Crohn's disease	0.00256	0.0278	CbGeAlD
Dapagliflozin—SLC5A4—Metabolism—PLA2G4F—Crohn's disease	0.00252	0.00387	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SEL1L—Crohn's disease	0.00249	0.00383	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00244	0.00375	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00244	0.00375	CbGpPWpGaD
Dapagliflozin—CYP1A1—skin of body—Crohn's disease	0.00243	0.0265	CbGeAlD
Dapagliflozin—UGT2B7—Metapathway biotransformation—GPX4—Crohn's disease	0.0024	0.00369	CbGpPWpGaD
Dapagliflozin—Diabetes mellitus—Prednisone—Crohn's disease	0.00237	0.00997	CcSEcCtD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00228	0.0035	CbGpPWpGaD
Dapagliflozin—Back pain—Mesalazine—Crohn's disease	0.00227	0.00955	CcSEcCtD
Dapagliflozin—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.00226	0.00347	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—LTF—Crohn's disease	0.00223	0.00344	CbGpPWpGaD
Dapagliflozin—Rash—Mercaptopurine—Crohn's disease	0.00222	0.00936	CcSEcCtD
Dapagliflozin—CYP1A1—mammalian vulva—Crohn's disease	0.00222	0.0242	CbGeAlD
Dapagliflozin—Dermatitis—Mercaptopurine—Crohn's disease	0.00222	0.00935	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00217	0.00916	CcSEcCtD
Dapagliflozin—Discomfort—Azathioprine—Crohn's disease	0.00216	0.00912	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00216	0.00332	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00216	0.00332	CbGpPWpGaD
Dapagliflozin—Angioedema—Mesalazine—Crohn's disease	0.00214	0.00902	CcSEcCtD
Dapagliflozin—SLC5A4—Metabolism—MTMR3—Crohn's disease	0.00214	0.00329	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00213	0.00327	CbGpPWpGaD
Dapagliflozin—Nausea—Mercaptopurine—Crohn's disease	0.00209	0.00882	CcSEcCtD
Dapagliflozin—Infection—Azathioprine—Crohn's disease	0.00208	0.00879	CcSEcCtD
Dapagliflozin—Skin disorder—Azathioprine—Crohn's disease	0.00204	0.00859	CcSEcCtD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00203	0.00313	CbGpPWpGaD
Dapagliflozin—Hypertension—Mesalazine—Crohn's disease	0.00202	0.00852	CcSEcCtD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00201	0.0031	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—RSPO3—Crohn's disease	0.00199	0.00306	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—RSPO3—Crohn's disease	0.00199	0.00306	CbGpPWpGaD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00198	0.00835	CcSEcCtD
Dapagliflozin—CYP1A2—digestive system—Crohn's disease	0.00197	0.0215	CbGeAlD
Dapagliflozin—Discomfort—Mesalazine—Crohn's disease	0.00197	0.0083	CcSEcCtD
Dapagliflozin—Hypotension—Azathioprine—Crohn's disease	0.00196	0.00827	CcSEcCtD
Dapagliflozin—UGT1A9—Metapathway biotransformation—GPX4—Crohn's disease	0.00195	0.003	CbGpPWpGaD
Dapagliflozin—CYP1A1—digestive system—Crohn's disease	0.00195	0.0212	CbGeAlD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00194	0.00299	CbGpPWpGaD
Dapagliflozin—Oedema—Mesalazine—Crohn's disease	0.00191	0.00806	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00191	0.00806	CcSEcCtD
Dapagliflozin—SLC5A2—Metabolism—PLA2G4F—Crohn's disease	0.00191	0.00293	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PLA2G4F—Crohn's disease	0.00191	0.00293	CbGpPWpGaD
Dapagliflozin—Infection—Mesalazine—Crohn's disease	0.0019	0.008	CcSEcCtD
Dapagliflozin—SLC5A2—Disease—SEL1L—Crohn's disease	0.00189	0.0029	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SEL1L—Crohn's disease	0.00189	0.0029	CbGpPWpGaD
Dapagliflozin—CYP1A1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.00188	0.00289	CbGpPWpGaD
Dapagliflozin—CYP2C9—digestive system—Crohn's disease	0.00187	0.0204	CbGeAlD
Dapagliflozin—Skin disorder—Mesalazine—Crohn's disease	0.00186	0.00783	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00185	0.00779	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00181	0.00764	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—GCKR—Crohn's disease	0.0018	0.00277	CbGpPWpGaD
Dapagliflozin—Hypotension—Mesalazine—Crohn's disease	0.00179	0.00753	CcSEcCtD
Dapagliflozin—CYP1A1—PPARA activates gene expression—FADS1—Crohn's disease	0.00173	0.00267	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.0017	0.00261	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—LTF—Crohn's disease	0.00169	0.0026	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—LTF—Crohn's disease	0.00169	0.0026	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—FADS1—Crohn's disease	0.00167	0.00256	CbGpPWpGaD
Dapagliflozin—Body temperature increased—Azathioprine—Crohn's disease	0.00166	0.00699	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00165	0.00696	CcSEcCtD
Dapagliflozin—Constipation—Mesalazine—Crohn's disease	0.00163	0.00689	CcSEcCtD
Dapagliflozin—SLC5A1—Metabolism—MTMR3—Crohn's disease	0.00162	0.00249	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—MTMR3—Crohn's disease	0.00162	0.00249	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.00159	0.00245	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SLC11A1—Crohn's disease	0.00159	0.00245	CbGpPWpGaD
Dapagliflozin—Acute coronary syndrome—Prednisone—Crohn's disease	0.00156	0.00659	CcSEcCtD
Dapagliflozin—SLC5A4—Metabolism—GPX4—Crohn's disease	0.00156	0.0024	CbGpPWpGaD
Dapagliflozin—Myocardial infarction—Prednisone—Crohn's disease	0.00155	0.00655	CcSEcCtD
Dapagliflozin—Hypersensitivity—Azathioprine—Crohn's disease	0.00155	0.00652	CcSEcCtD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00153	0.00235	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00153	0.00235	CbGpPWpGaD
Dapagliflozin—Urticaria—Mesalazine—Crohn's disease	0.00152	0.0064	CcSEcCtD
Dapagliflozin—Body temperature increased—Mesalazine—Crohn's disease	0.00151	0.00637	CcSEcCtD
Dapagliflozin—SLC5A4—Metabolism—GCKR—Crohn's disease	0.00151	0.00232	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PLA2G4F—Crohn's disease	0.00147	0.00227	CbGpPWpGaD
Dapagliflozin—CYP3A4—digestive system—Crohn's disease	0.00143	0.0155	CbGeAlD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00142	0.00219	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Mesalazine—Crohn's disease	0.00141	0.00594	CcSEcCtD
Dapagliflozin—CYP2D6—digestive system—Crohn's disease	0.00141	0.0153	CbGeAlD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—ALB—Crohn's disease	0.0014	0.00216	CbGpPWpGaD
Dapagliflozin—Connective tissue disorder—Prednisone—Crohn's disease	0.0014	0.0059	CcSEcCtD
Dapagliflozin—Dizziness—Azathioprine—Crohn's disease	0.00139	0.00585	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—RBX1—Crohn's disease	0.00136	0.0021	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—HSPA1B—Crohn's disease	0.00136	0.0021	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—GCKR—Crohn's disease	0.00136	0.0021	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—GCKR—Crohn's disease	0.00136	0.0021	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00136	0.00209	CbGpPWpGaD
Dapagliflozin—ABCB1—epithelium—Crohn's disease	0.00133	0.0145	CbGeAlD
Dapagliflozin—Rash—Azathioprine—Crohn's disease	0.00132	0.00558	CcSEcCtD
Dapagliflozin—Dermatitis—Azathioprine—Crohn's disease	0.00132	0.00557	CcSEcCtD
Dapagliflozin—Headache—Azathioprine—Crohn's disease	0.00131	0.00554	CcSEcCtD
Dapagliflozin—Dizziness—Mesalazine—Crohn's disease	0.00126	0.00533	CcSEcCtD
Dapagliflozin—SLC5A2—Metabolism—FADS1—Crohn's disease	0.00126	0.00194	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—FADS1—Crohn's disease	0.00126	0.00194	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MTMR3—Crohn's disease	0.00125	0.00193	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00125	0.00192	CbGpPWpGaD
Dapagliflozin—Nausea—Azathioprine—Crohn's disease	0.00125	0.00525	CcSEcCtD
Dapagliflozin—Malnutrition—Prednisone—Crohn's disease	0.00124	0.00522	CcSEcCtD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00122	0.00188	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SLC11A1—Crohn's disease	0.00121	0.00186	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SLC11A1—Crohn's disease	0.00121	0.00186	CbGpPWpGaD
Dapagliflozin—Rash—Mesalazine—Crohn's disease	0.00121	0.00508	CcSEcCtD
Dapagliflozin—Dermatitis—Mesalazine—Crohn's disease	0.0012	0.00508	CcSEcCtD
Dapagliflozin—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.0012	0.00184	CbGpPWpGaD
Dapagliflozin—Headache—Mesalazine—Crohn's disease	0.0012	0.00505	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—UBE2D1—Crohn's disease	0.0012	0.00184	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.00119	0.00182	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GPX4—Crohn's disease	0.00118	0.00182	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GPX4—Crohn's disease	0.00118	0.00182	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00117	0.0018	CbGpPWpGaD
Dapagliflozin—ABCB1—mammalian vulva—Crohn's disease	0.00115	0.0125	CbGeAlD
Dapagliflozin—SLC5A2—Metabolism—GCKR—Crohn's disease	0.00114	0.00176	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GCKR—Crohn's disease	0.00114	0.00176	CbGpPWpGaD
Dapagliflozin—Nausea—Mesalazine—Crohn's disease	0.00114	0.00479	CcSEcCtD
Dapagliflozin—Angioedema—Prednisone—Crohn's disease	0.00113	0.00477	CcSEcCtD
Dapagliflozin—CYP1A1—Metapathway biotransformation—GPX4—Crohn's disease	0.00112	0.00172	CbGpPWpGaD
Dapagliflozin—CYP1A1—lymph node—Crohn's disease	0.00111	0.0121	CbGeAlD
Dapagliflozin—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.0011	0.0017	CbGpPWpGaD
Dapagliflozin—Hypertension—Prednisone—Crohn's disease	0.00107	0.00451	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00105	0.00442	CcSEcCtD
Dapagliflozin—Discomfort—Prednisone—Crohn's disease	0.00104	0.00439	CcSEcCtD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00104	0.0016	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—RBX1—Crohn's disease	0.00103	0.00159	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—HSPA1B—Crohn's disease	0.00103	0.00159	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—RBX1—Crohn's disease	0.00103	0.00159	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—HSPA1B—Crohn's disease	0.00103	0.00159	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.00103	0.00159	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—ALB—Crohn's disease	0.00102	0.00158	CbGpPWpGaD
Dapagliflozin—ABCB1—lymphoid tissue—Crohn's disease	0.00102	0.0111	CbGeAlD
Dapagliflozin—Oedema—Prednisone—Crohn's disease	0.00101	0.00426	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisone—Crohn's disease	0.00101	0.00426	CcSEcCtD
Dapagliflozin—ABCB1—digestive system—Crohn's disease	0.00101	0.011	CbGeAlD
Dapagliflozin—Infection—Prednisone—Crohn's disease	0.001	0.00423	CcSEcCtD
Dapagliflozin—Skin disorder—Prednisone—Crohn's disease	0.000982	0.00414	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisone—Crohn's disease	0.000978	0.00412	CcSEcCtD
Dapagliflozin—UGT2B4—Metabolism—FADS1—Crohn's disease	0.000975	0.0015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000914	0.00141	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GPX4—Crohn's disease	0.000913	0.00141	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—UBE2D1—Crohn's disease	0.000906	0.00139	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—UBE2D1—Crohn's disease	0.000906	0.00139	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000895	0.00138	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GCKR—Crohn's disease	0.000882	0.00136	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000876	0.00135	CbGpPWpGaD
Dapagliflozin—Constipation—Prednisone—Crohn's disease	0.000865	0.00365	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—SMAD3—Crohn's disease	0.000855	0.00132	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000842	0.0013	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000835	0.00129	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00082	0.00126	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000815	0.00126	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00081	0.00125	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000806	0.00124	CbGpPWpGaD
Dapagliflozin—Urticaria—Prednisone—Crohn's disease	0.000803	0.00339	CcSEcCtD
Dapagliflozin—Body temperature increased—Prednisone—Crohn's disease	0.000799	0.00337	CcSEcCtD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000776	0.00119	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000776	0.00119	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000759	0.00117	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Prednisone—Crohn's disease	0.000745	0.00314	CcSEcCtD
Dapagliflozin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000718	0.00111	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000714	0.0011	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000703	0.00108	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	0.00067	0.00103	CbGpPWpGaD
Dapagliflozin—Dizziness—Prednisone—Crohn's disease	0.000669	0.00282	CcSEcCtD
Dapagliflozin—SLC5A1—Disease—SMAD3—Crohn's disease	0.000648	0.000998	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SMAD3—Crohn's disease	0.000648	0.000998	CbGpPWpGaD
Dapagliflozin—Rash—Prednisone—Crohn's disease	0.000638	0.00269	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisone—Crohn's disease	0.000637	0.00269	CcSEcCtD
Dapagliflozin—Headache—Prednisone—Crohn's disease	0.000634	0.00267	CcSEcCtD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000612	0.000942	CbGpPWpGaD
Dapagliflozin—Nausea—Prednisone—Crohn's disease	0.000601	0.00253	CcSEcCtD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000597	0.000919	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000592	0.000911	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000592	0.000911	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000583	0.000897	CbGpPWpGaD
Dapagliflozin—ABCB1—lymph node—Crohn's disease	0.000577	0.00629	CbGeAlD
Dapagliflozin—UGT2B7—Metabolism—MTMR3—Crohn's disease	0.00057	0.000877	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000559	0.00086	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TYK2—Crohn's disease	0.000558	0.000859	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000551	0.000848	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	0.000545	0.000838	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—JAK2—Crohn's disease	0.000532	0.000819	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000524	0.000807	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000523	0.000805	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00052	0.0008	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000506	0.000779	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD4—Crohn's disease	0.000505	0.000777	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—Crohn's disease	0.000501	0.000771	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ALB—Crohn's disease	0.00048	0.000738	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000474	0.000729	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000465	0.000716	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MTMR3—Crohn's disease	0.000463	0.000713	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000454	0.000698	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000454	0.000698	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000448	0.000689	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000446	0.000686	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—FADS1—Crohn's disease	0.000444	0.000683	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.00044	0.000678	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000436	0.000671	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TYK2—Crohn's disease	0.000423	0.000651	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TYK2—Crohn's disease	0.000423	0.000651	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000423	0.00065	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	0.00042	0.000646	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—Crohn's disease	0.00042	0.000646	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GPX4—Crohn's disease	0.000416	0.00064	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—JAK2—Crohn's disease	0.000403	0.000621	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—JAK2—Crohn's disease	0.000403	0.000621	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GCKR—Crohn's disease	0.000402	0.000618	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—STAT3—Crohn's disease	0.000391	0.000601	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD4—Crohn's disease	0.000382	0.000589	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD4—Crohn's disease	0.000382	0.000589	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000381	0.000586	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—Crohn's disease	0.00038	0.000584	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—Crohn's disease	0.00038	0.000584	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000377	0.000581	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000377	0.000581	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ALB—Crohn's disease	0.000363	0.000559	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ALB—Crohn's disease	0.000363	0.000559	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—FADS1—Crohn's disease	0.000361	0.000555	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MTMR3—Crohn's disease	0.000357	0.00055	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000347	0.000534	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GPX4—Crohn's disease	0.000338	0.00052	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GCKR—Crohn's disease	0.000326	0.000502	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000325	0.0005	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00032	0.000492	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—Crohn's disease	0.000318	0.000489	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—Crohn's disease	0.000318	0.000489	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	0.000313	0.000482	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000307	0.000472	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000297	0.000457	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—STAT3—Crohn's disease	0.000296	0.000456	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—STAT3—Crohn's disease	0.000296	0.000456	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000283	0.000435	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ALB—Crohn's disease	0.000281	0.000432	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—FADS1—Crohn's disease	0.000278	0.000428	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000278	0.000428	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—Crohn's disease	0.000273	0.00042	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTMR3—Crohn's disease	0.000266	0.000409	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GPX4—Crohn's disease	0.00026	0.000401	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GCKR—Crohn's disease	0.000252	0.000387	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.00025	0.000385	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—Crohn's disease	0.000246	0.000378	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000235	0.000362	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000233	0.000359	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000233	0.000359	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000224	0.000345	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000212	0.000327	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—FADS1—Crohn's disease	0.000207	0.000319	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—Crohn's disease	0.000207	0.000318	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—Crohn's disease	0.000207	0.000318	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000204	0.000314	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.0002	0.000308	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000199	0.000307	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000198	0.000306	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX4—Crohn's disease	0.000194	0.000299	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GCKR—Crohn's disease	0.000187	0.000288	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.00017	0.000261	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—FADS1—Crohn's disease	0.000166	0.000255	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000156	0.00024	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX4—Crohn's disease	0.000155	0.000239	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—FADS1—Crohn's disease	0.000155	0.000238	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000154	0.000237	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000151	0.000233	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GCKR—Crohn's disease	0.00015	0.00023	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000146	0.000225	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX4—Crohn's disease	0.000145	0.000223	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000141	0.000217	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GCKR—Crohn's disease	0.00014	0.000215	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000134	0.000206	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—FADS1—Crohn's disease	0.000132	0.000203	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000131	0.000201	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ALB—Crohn's disease	0.000128	0.000197	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX4—Crohn's disease	0.000124	0.00019	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GCKR—Crohn's disease	0.00012	0.000184	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000117	0.00018	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—Crohn's disease	0.000112	0.000172	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—Crohn's disease	0.000104	0.00016	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000102	0.000157	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000102	0.000157	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.99e-05	0.000154	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX4—Crohn's disease	9.55e-05	0.000147	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GCKR—Crohn's disease	9.22e-05	0.000142	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—Crohn's disease	9.09e-05	0.00014	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.74e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.54e-05	0.000131	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—Crohn's disease	8.01e-05	0.000123	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.47e-05	0.000115	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—Crohn's disease	7e-05	0.000108	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—Crohn's disease	5.97e-05	9.18e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—Crohn's disease	5.22e-05	8.03e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—Crohn's disease	4.76e-05	7.33e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—Crohn's disease	4.49e-05	6.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—Crohn's disease	4.45e-05	6.85e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—Crohn's disease	4.17e-05	6.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.93e-05	6.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—Crohn's disease	3.89e-05	5.99e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—Crohn's disease	3.8e-05	5.85e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—Crohn's disease	3.33e-05	5.12e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—Crohn's disease	2.94e-05	4.52e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.57e-05	3.95e-05	CbGpPWpGaD
